ÂÜÀòÂÒÂ×

Dan Adams has extensive experience in the field of phototransduction and neurodegenerative disorders. As the Chief Science Officer at PhotoPharmics, Inc., Dan oversees clinical affairs and manages clinical research for human clinical trials and pre-commercialization efforts. Prior to this role, Dan worked at both Philips and Apollo Light Systems, focusing on application of phototransduction in circadian related disorders. Dan holds a Bachelor's degree from Brigham Young University.